Allergan plc (AGN) is an interesting player in the Healthcare space, with a focus on Drugs – Generic. The stock has been active on the tape, currently trading at $163.58, down from yesterday’s close by -0.63%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Allergan plc (AGN) currently trades with a market capitalization of $54.75 Billion. That value represents a market adjusting for revenues that have been growing by 11.38 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of $3.44 Billion over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of $4.73 on a per share basis this quarter. Perhaps, that suggests something about why 0.61% of the outstanding share supply is held by institutional investors.
No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Allergan plc recorded a 52-week high of $256.80. It is now trading 93.22% off that level. The stock is trading $173.00 its 50-day moving average by 9.42%. The stock carved out a 52-week low down at $160.07.
In recent action, Allergan plc (AGN) has made a move of -5.90% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 3.19% with $331.77 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of AGN.